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Purpose: Short life expectancy influences decision-making 
when treating very old patients with acute ischemic stroke 
(AIS). We investigated mortality and survival duration in very 
old AIS patients (≥ 80 years) who received hospital care. 
Patients and Methods: Mortality data were obtained from med-
ical records, structured telephone inquiries, death certificates 
from the Korean National Statistical Office, and social security 
data 5 ± 1.9 years after stroke onset. Age, gender, vascular risk 
factors, and functional outcomes from modified Rankin scales 
(MRS) at discharge were analyzed as predictors of mortality. 
Results:  Among 134 patients, 92 (68.7%) died. On Kaplan- 
Meier analysis, duration of survival of patients aged 80 - 84 
years was longer than those aged 85 - 89 or 90 - 94 (24 ± 6.4, 
8 ± 7.3, 7 ± 2.0 months, respectively, p = 0.002). Duration of 
survival of patients discharged in a state of MRS 0 - 1 was 
longer than the remaining groups at 47 ± 4.8 months (p < 
0.001). In Cox proportional hazard analysis, age and MRS at 
discharge were independent predictors of mortality. Conclusion: 
Long-term outcomes of very old patients with AIS are not uni-
formly grave, therefore predictors of mortality and estimated du-
ration of survival should be considered during decision- mak-
ing for treatment.
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INTRODUCTION
With prolonged life expectancy, the number of 
v e r y  o l d  p a t i e n t s  i n  a c u t e stroke units has been 
increasing. Early or in-hospital mortality of very 
old patients is higher and their active medical care 
is poorer than younger patients.
1-4 Short life 
expectancy may influence active medical care in 
very old patients.
Despite the lack of evidence-based studies on 
patients beyond the age of 80 years, carotid endar-
terectomy or thrombolysis has been performed in 
a selected numbers of very old patients.
5-9 Recent 
case studies recommended that the very old 
should not be denied treatment on the basis of age 
alone, therefore other prognostic factors would be 
useful in selecting candidates for active inter-
vention among very old patients with acute ische-
mic stroke (AIS).
7,8
Most previous studies compared the prognosis 
of very old stroke patients with that of younger 
patients or assessed the prognosis at discharge or 
3 months later.
2-4,9-11 Very few studies have focused 
on the long-term outcomes or survival duration of 
very old stroke patients. The Copenhagen stroke 
study analyzed long-term prognosis in very old 
stroke patients but prognostic factors among very 
old stroke patients were not separately analyzed.
11 
Imbalance in baseline variables between very old 
and younger groups may contribute to the poorer 
prognosis in very old stroke patients after acute 
treatment.
9 Long-term prognosis for very old 
stroke patients was not uniformly poor, therefore 
analysis of long-term prognostic factors among 
very old stroke patients may be important in 
deciding on the treatment of very old AIS patients. 
This study investigated long-term mortality, its 
predictors, and duration of survival among very 
old patients with AIS.Long-Term Outcomes of Ischemic Stroke in Very Old 401
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PATIENTS AND METHODS
This study was based on data from Hallym 
Stroke Registry (HSR) of the Hallym University 
Medical Center, a prospective, multicenter, hospital- 
based stroke data bank of acute stroke patients 
who were admitted within 7 days of onset of 
stroke.
12 The diagnosis of ischemic stroke was 
based on clinical findings and neuroimaging 
studies simultaneously reviewed by 2 or more 
experienced neurologists. Data on ischemic stroke 
patients aged ≥ 80 years were obtained from the 
HSR of Hangang Sacred Heart Hospital from 
February 1996 to August 2003 and the HSR of 
Hallym University Sacred Heart Hospital from 
February 1999 to August 2003. Seventy of 463 
(15.1%) patients in the HSR of Hangang Sacred 
Heart Hospital and 64 of 781 (8.2%) patients in the 
HSR of Hallym University Sacred Heart Hospital 
served as subjects. Hallym University Sacred 
Heart Hospital was founded by former employees 
of Hangang Sacred Heart Hospital in 1999. A total 
of 134 patients were selected from the 2 hospitals. 
Conventional risk factors for stroke such as pre-
vious history of stroke, hypertension, diabetes 
mellitus, hyperlipidemia, smoking habits, atrial fi-
brillation, and NIH stroke scale score upon admis-
sion were obtained from HSR data on each 
patient.
12 Hypertension was defined as systolic 
blood pressure ≥ 140 mm Hg or diastolic blood 
pressure of ≥ 90 mm Hg based on repeated meas-
urements or a history of taking anti- hypertensive 
medication. Diabetes mellitus was diagnosed if a 
patient had a history of diabetes mellitus with 
current treatment, or fasting blood glucose level 
≥ 126 mg/dL. A patient was considered to have 
hyperlipidemia if there was a history of hyper-
lipidemia with current treatment, if fasting serum 
cholesterol level was ≥ 240 mg/dL, or if fasting 
triglyceride level was ≥ 200 mg/dL. Current in-
farcts were classified according to TOAST cri-
teria,
13 and functional outcomes were measured 
by means of modified Rankin scales (MRS) at dis-
charge as follows: no symptom (MRS 0), symptom 
but no disability (MRS 1), mild disability (MRS 2), 
moderate disability with independent walking 
(MRS 3), severe disability (MRS 4), bedridden 
state (MRS 5), and death (MRS 6).
14
Information on mortality was obtained from 
January to July 2005, through medical records, 
structured telephone phone inquiries, death 
certificates from the Korean National Statistical 
Office from 1996 to 2002, and social security data. 
Probable causes of death were categorized based 
on patients’ medical charts, information from 
families through phone interviews, and death 
certificates from the Korean National Statistical 
Office. The categories were index stroke, recurrent 
stroke, heart disease, infection, cancer, another 
known cause, and unknown causes.
Cox proportional hazard analysis was used to 
calculate the hazard ratio (HR) and 95% confidence 
interval (CI) for mortality. Demographic charac-
teristics, conventional risk factors for stroke, and 
functional status at discharge were analyzed for 
predictors of mortality. A p value < 0.05 was chosen 
for statistical significance. Kaplan-Meier survival 
analysis was done with significant predictors of 
mortality. Statistical analyses were undertaken 
using SPSS software.
RESULTS
A total of 134 patients were included in this 
study: 61 men and 73 women (median age, 82 
years; range, 80 - 94). Demographic characteristics 
and vascular risk factor are shown in Table 1. 
After admission, all patients were treated with 
antiplatelet agents, 6 patients with an intravenous 
recombinant tissue plasminogen activator (rtPA), 
and 22 patients with intravenous conventional 
heparin, based on physician's decisions. 
According to TOAST classification, 44 patients 
were classified as having large vessel disease, 37 
as cardioembolism, 33 as small vessel disease, 19 
as undetermined causes, and 1 as another de-
termined cause. 
Median length of hospital stay was 10 days. 
Within 90 days, 132 patients (98.5%) were 
discharged. Functional status at discharge was 
MRS 0 - 1 in 22 patients (16.4%), MRS 2 - 3 in 47 
(35.1%), MRS 4 - 5 in 45 (33.6%), and MRS 6 (death 
during hospital stay) in 20 (14.9%). A total of 101 
patients were discharged to their homes and 13 
were transferred to other hospitals. Secondary 
preventive medications at hospital discharge were 
antiplatelet agents for 91 patients and oral anti-Yang-Ki Minn, et al. 402
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Table 1. Baseline Characteristics, Hospital Stay, and 
Functional Status at Discharge (n = 134)
Characteristics   Value
Age, median (range)  82 (80 - 94)
Women (%)  73 (54.5)
NIHSS score at admission (mean ± SD)  9.5 ± 7.95
Previous stroke (%)  31 (23.1)
Hypertension (%) 103 (76.9)
Diabetes mellitus (%)  15 (11.2)
Hyperlipidemia (%)  22 (16.4)
Atrial fibrillation (%)  39 (29.1)
Smoking (%)  31 (23.1)
Heart disease (%)  13 (9.7)
NIHSS, National Institutes of Health Stroke Scale; SD, standard 
deviation.
Fig. 1. Survival plot by Kaplan-Meier method according to
3 age groups. Solid line represents 91 patients aged 80 -
84 years, dotted line represents 34 patients aged 85 - 89 
years, and broken line represents 9 patients aged 90 - 94
years. Numbers in brackets show percentage of survival
at the time. P  value of log rank test is 0.002.
coagulants for 16. Seven patients did not receive 
any antiplatelet agent or oral anticoagulant at dis-
charge because of bleeding complications during 
hospital stay. 
Mortality data were obtained at mean 5 ± 1.9 
years (range, 2 - 9 years) after stroke onset: 58 
patients from medical records, 45 from structured 
telephone phone inquiries, 21 from the Korean 
National Statistical Office from 1996 to 2002, and 
10 from social security data. Ninety-two patients 
(68.7%) died of the following causes: index stroke 
(44 patients), recurrent stroke (3), heart disease (7), 
infection (5), cancer (8), or another known or 
unknown cause (25). Among 92 patients who died 
during follow up, 54 (58.7%) died of vascular 
causes and 38 (41.3%) of non vascular or 
unknown causes. 
On Kaplan-Meier analysis, median duration of 
estimated survival was 24 ± 6.4 months for 91 
patients aged 80 - 84 years, 8 ± 7.3 months for 34 
patients aged 85 - 89 years, and 7 ± 2.0 months for 
9 patients aged 90 - 94 years (Fig. 1, p =0 . 0 0 2 ) .  
Median survival duration according to functional 
status at discharge was 47 ± 4.8 months for MRS 
0 - 1, 39 ± 9.0 months for MRS 2 - 3, 5 ± 1.1 months 
for MRS 4 - 5, and 1 month for MRS 6 (p<0.001). 
After excluding patients who died in hospital, 
demographic characteristics, vascular risk factors, 
NIH stroke scale at admission, stroke subtype, 
treatment with intravenous rtPA, and functional 
status at discharge were analyzed for predictors of 
mortality in a Cox proportional hazard model. As 
shown in Table 2, age (HR 1.12, 95% CI 1.01 - 1.24, 
p = 0.039) and MRS 4 - 5 status at discharge (HR 
8.1, 95% CI 2.20 - 29.64, p = 0.002) were significant 
predictors of mortality. When the analysis was 
performed in all 134 patients, independent 
predictors of mortality did not change.
DISCUSSION
According to in this hospital-based retrospective 
study, about two-thirds of AIS patients aged ≥ 80 
years died at a mean of 5 ± 1.9 years (range, 2 - 9 
years) after stroke onset. To obtain more infor-
mation about follow-up status, national statistical 
data based on the personal identification number 
can be used to study long-term prognoses.
1,11  Age 80 
was selected as the cutoff, similar to recent studies 
focused on the treatment of the very old.
7-8,15
This study had some limitations. First, data 
from 2 hospitals were studied because the number 
of patients aged 80 years and older per hospital 
was not sufficient for analysis of predictors of 
mortality. The initial clinical data of the two Long-Term Outcomes of Ischemic Stroke in Very Old 403
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Table 2. Cox Proportional Hazard Analysis of Death After Excluding Patients Who Died in Hospital
Predictors Hazard ratio 95% CI p  value
Age 1.12 1.01 - 1.24 0.039
Women 0.53 0.28 - 1.00 0.05
Large artery atherosclerosis* 0.56 0.21 - 1.46 0.235
Small vessel occlusion* 0.50 0.19 - 1.33 0.166
Cardioembolism* 0.53 0.28 - 1.93 0.534
NIHSS at admission 1.03 0.98 - 1.08 0.257
Intravenous rtPA thrombolysis 0.29 0.70 - 1.23 0.093
Functional status at discharge 
MRS 0 - 1
MRS 2 - 3
MRS 4 - 5
   1
3.38
8.07
0.96 - 11.89
2.20 - 29.64
0.003
0.058
0.002
CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; rtPA, recombinant tissue plasminogen activator; MRS, 
modified Rankin scale.
*Large artery disease, small vessel occlusion, and cardioembolism were classified according to TOAST.
hospitals were similar. Second, although collection 
of patient outcomes at a fixed interval was reason-
able, functional status was assessed only upon 
discharge.
16 Median duration of hospital stay was 
10 days and length of hospital stay was not an 
independent predictor of mortality in a separate 
analysis. Third, pre-stroke disability, comorbidity 
other than vascular risk factors, and recurrence of 
stroke may influence mortality after a stroke,
1,11,17 
but these variables were not assessed due to 
limitations because of the nature of retrospective 
study. Finally, we did not compare the mortality 
of older and younger stroke patients. The comparison 
may be able to identify specific predictors of mor-
tality in older patients compared to younger patients. 
Age and functional status at discharge were 
significant predictors of mortality. We classified 
patients into 3 age groups and median duration 
of survival was analyzed separately. Since the 
number of patients aged 90 - 94 years was small, 
median survival durations of the 2 octogenarian 
groups could be clinically useful as a reference 
value. 
Functional status at discharge was a significant 
predictor of mortality. NIH stroke scale scores 
were not significant because of the correlation 
between the outcomes at discharge and NIH 
stroke scale scores upon admission (r = 0.736, p<  
0.001). Functional status at discharge is just one 
short-tem outcome parameter with more influence 
on long-term outcome.
Atrial fibrillation was not an independent pre-
dictor of mortality in this study. The significance 
of atrial fibrillation was inconsistent with previous 
studies.
1,4,11 In a study that separately analyzed 
the prognostic factors of AIS patients aged ≥ 80 
years, atrial fibrillation was not a significant pre-
dictor for older patients,
1 and previous histories of 
stroke did not influence mortality. A possible ex-
planation is that only patients with mild disability 
from previous strokes could survive until their 80s 
and most very old patients with first-ever stroke 
in the study had a silent infarct on MRI.
18 Sub-
types of stroke were not an independent predictor 
o f  m o r t a l i t y .  D e  J o n g  e t  al. reported stroke sub-
types were one of the independent predictors of 
30-day case fatality but not a predictor of later 
mortality.
19
In the present study, 6 patients received 
thrombolysis with rtPA and the treatment did not 
give significantly influence long-term mortality. 
However, the number of patients was very small 
and the functional outcomes at final follow up 
were not analyzed, indicating that the efficacy of 
intravenous thrombolysis in stroke patients aged 
≥ 80 years was not assessed in this study. Recent Yang-Ki Minn, et al. 404
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systemic review also suggested that it is reasonable 
to include older patients in randomized placebo- 
controlled trials to analyze efficacy and safety of 
treatment.
9
In recent studies, the proportion of patients 
aged ≥ 80 years was 30.2 - 53.7% among patients 
with AIS.
1,4  However, long-term outcomes or sur-
vival duration after stroke in those patients have 
not been frequently studied. Miller et al. reported 
that median survival of patients with carotid 
stenosis after carotid endarterectomy was 6.6 
years in patients aged ≥ 80 years, but median pa-
tient survival with ischemic stroke was not sepa-
rately analyzed.
7 Residual life expectancy of less 
than 5 years was one of the exclusion criteria for 
carotid endarterectomy in symptomatic patients,
5 
however, the longest median duration of survival 
o f  a n y  s u b g r o u p  i n  t h e present study was less 
than 4 years in this study, and about 10% of the 
patients aged ≥ 85 years were independently 
alive 5 years after stroke onset in the Copenhagen 
stroke study.
11  Further study with a larger pop-
ulation seems to be needed to evaluate survival 
after stroke and establish more practical criteria of 
active intervention for very old AIS patients.
In conclusion, age and functional outcomes at 
discharge were significant predictors of long-term 
mortality. These predictors and estimated dura-
tion of survival should be considered during the 
decision-making process on the treatment of very 
old AIS patients. 
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